WO2012170098A3 - Arbovirus inhibitors and uses thereof - Google Patents
Arbovirus inhibitors and uses thereof Download PDFInfo
- Publication number
- WO2012170098A3 WO2012170098A3 PCT/US2012/029634 US2012029634W WO2012170098A3 WO 2012170098 A3 WO2012170098 A3 WO 2012170098A3 US 2012029634 W US2012029634 W US 2012029634W WO 2012170098 A3 WO2012170098 A3 WO 2012170098A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitors
- arbovirus
- present
- arboviruses
- discovery
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Abstract
The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161470038P | 2011-03-31 | 2011-03-31 | |
US61/470,038 | 2011-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012170098A2 WO2012170098A2 (en) | 2012-12-13 |
WO2012170098A3 true WO2012170098A3 (en) | 2013-01-31 |
Family
ID=46928024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/029634 WO2012170098A2 (en) | 2011-03-31 | 2012-03-19 | Arbovirus inhibitors and uses thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US8846684B2 (en) |
WO (1) | WO2012170098A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2927023C (en) * | 2013-10-10 | 2022-08-02 | The Regents Of The University Of Michigan | Deubiquitinase inhibitors and methods for use of the same |
EP3215150B1 (en) * | 2014-11-07 | 2022-07-20 | The Regents of The University of Michigan | Inhibitors of myocardin-related transcription factor and serum response factor (mrtf/srf)-mediated gene transcription and methods for use of the same |
UY38434A (en) * | 2018-11-02 | 2020-05-29 | Aicuris Gmbh & Co Kg | NEW 6,7-DIHYDRO-4H-PYRAZOLE [1,5-A] PIRAZIN INDOL-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) |
CA3150147A1 (en) * | 2019-09-05 | 2021-03-11 | Guimin ZHANG | Magl inhibitor, preparation method and use thereof |
US20240059688A1 (en) * | 2020-12-22 | 2024-02-22 | Luxembourg Institute Of Health (Lih) | Conolidine analogues as selective ackr3 modulators for the treatment of cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070155761A1 (en) * | 2006-01-05 | 2007-07-05 | Caterina Bissantz | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
US20080200491A1 (en) * | 2005-06-22 | 2008-08-21 | Thuy-Anh Tran | 1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2647596C (en) | 2006-04-04 | 2012-06-12 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
-
2012
- 2012-03-19 US US13/423,647 patent/US8846684B2/en active Active
- 2012-03-19 WO PCT/US2012/029634 patent/WO2012170098A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080200491A1 (en) * | 2005-06-22 | 2008-08-21 | Thuy-Anh Tran | 1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel |
US20070155761A1 (en) * | 2006-01-05 | 2007-07-05 | Caterina Bissantz | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
Also Published As
Publication number | Publication date |
---|---|
US20120252807A1 (en) | 2012-10-04 |
US8846684B2 (en) | 2014-09-30 |
WO2012170098A2 (en) | 2012-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012159051A3 (en) | Chemically modified graphene | |
WO2014014835A3 (en) | Criystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
WO2012100224A3 (en) | Preparation of metal-triazolate frameworks | |
IL235944A0 (en) | Β-lactamase inhibitor compounds, compositions comprising same, methods of producing same and uses thereof | |
EP2747767B8 (en) | Certain chemical entities, compositions, and methods | |
IL239218A0 (en) | Atr kinase inhibitor compounds, compositions comprising same, uses thereof and processes for producing same | |
WO2012140274A3 (en) | Agonists and antagonists of the wnt pathway | |
WO2012138981A3 (en) | New intermediates and processes for preparing ticagrelor | |
WO2012158843A3 (en) | Kinase inhibitors | |
AU2012289429A8 (en) | Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof | |
MX361279B (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
WO2012024427A3 (en) | Human facilitating cells and uses thereof | |
WO2012129341A3 (en) | Disease detection in plants | |
WO2013003298A3 (en) | Inhibitors of pde10 | |
PL2922893T3 (en) | Moisture-curing compositions, processes for producing same and use of same | |
IL236463A0 (en) | Bifluorodioxalane-amino-benzimidazole compounds, compositions comprising same, processes for producing same and uses thereof | |
EP2729464B8 (en) | Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors | |
WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
EP2691396A4 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
WO2012170098A3 (en) | Arbovirus inhibitors and uses thereof | |
WO2012106680A8 (en) | Methods and compositions for chemical drying and producing struvite | |
WO2013155338A3 (en) | Substituted benzamides and their uses | |
MX2012008473A (en) | Single-chamber evaporator and the use thereof in chemical synthesis. | |
GB201107985D0 (en) | Process | |
WO2012154879A3 (en) | Autophagy inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12797599 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12797599 Country of ref document: EP Kind code of ref document: A2 |